Literature DB >> 21329489

Urinary p-cresol is elevated in small children with severe autism spectrum disorder.

Laura Altieri1, Cristina Neri, Roberto Sacco, Paolo Curatolo, Arianna Benvenuto, Filippo Muratori, Elisa Santocchi, Carmela Bravaccio, Carlo Lenti, Monica Saccani, Roberto Rigardetto, Marina Gandione, Andrea Urbani, Antonio M Persico.   

Abstract

Several studies have described in autistic patients an overgrowth of unusual gut bacterial strains, able to push the fermentation of tyrosine up to the formation of p-cresol. We compared levels of urinary p-cresol, measured by high-performance liquid chromatography-ultraviolet, in 59 matched case-control pairs. Urinary p-cresol was significantly elevated in autistic children smaller than 8 years of age (p < 0.01), typically females (p < 0.05), and more severely affected regardless of sex (p < 0.05). Urinary cotinine measurements excluded smoking-related hydrocarbon contaminations as contributors to these differences. Hence, elevated urinary p-cresol may serve as a biomarker of autism liability in small children, especially females and more severely affected males.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329489     DOI: 10.3109/1354750X.2010.548010

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  42 in total

Review 1.  Xenobiotics: Interaction with the Intestinal Microflora.

Authors:  Kun Lu; Ridwan Mahbub; James G Fox
Journal:  ILAR J       Date:  2015

2.  Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder.

Authors:  Lv Wang; Claus Thagaard Christophersen; Michael Joseph Sorich; Jacobus Petrus Gerber; Manya Therese Angley; Michael Allan Conlon
Journal:  Dig Dis Sci       Date:  2012-04-26       Impact factor: 3.199

3.  Microbial-Derived Metabolites Reflect an Altered Intestinal Microbiota during Catch-Up Growth in Undernourished Neonatal Mice.

Authors:  Geoffrey A Preidis; Nadim J Ajami; Matthew C Wong; Brooke C Bessard; Margaret E Conner; Joseph F Petrosino
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

4.  Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism.

Authors:  Lv Wang; Claus T Christophersen; Michael J Sorich; Jacobus P Gerber; Manya T Angley; Michael A Conlon
Journal:  Appl Environ Microbiol       Date:  2011-07-22       Impact factor: 4.792

Review 5.  Defining Dysbiosis in Disorders of Movement and Motivation.

Authors:  Christopher T Fields; Timothy R Sampson; Annadora J Bruce-Keller; Drew D Kiraly; Elaine Y Hsiao; Geert J de Vries
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

Review 6.  Natural products as mediators of disease.

Authors:  Neha Garg; Tal Luzzatto-Knaan; Alexey V Melnik; Andrés Mauricio Caraballo-Rodríguez; Dimitrios J Floros; Daniel Petras; Rachel Gregor; Pieter C Dorrestein; Vanessa V Phelan
Journal:  Nat Prod Rep       Date:  2016-11-22       Impact factor: 13.423

Review 7.  The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.

Authors:  George E Jaskiw; Mark E Obrenovich; Curtis J Donskey
Journal:  Psychopharmacology (Berl)       Date:  2019-06-13       Impact factor: 4.530

Review 8.  Autism Spectrum Disorder as a Brain-Gut-Microbiome Axis Disorder.

Authors:  Virginia Saurman; Kara G Margolis; Ruth Ann Luna
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

9.  Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders.

Authors:  Elaine Y Hsiao; Sara W McBride; Sophia Hsien; Gil Sharon; Embriette R Hyde; Tyler McCue; Julian A Codelli; Janet Chow; Sarah E Reisman; Joseph F Petrosino; Paul H Patterson; Sarkis K Mazmanian
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

Review 10.  Biomarkers in autism spectrum disorder: the old and the new.

Authors:  Barbara Ruggeri; Ugis Sarkans; Gunter Schumann; Antonio M Persico
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.